Companies
Reckitt gets US permission to acquire Adams
By Richard Williams
Font Scale: 
Posted 08 January 2008 @ 07:54 am GMT
UK based Reckitt Benckiser Group have said that they have received antitrust approval from US regulators to acquire US drugmaker Adams Respiratory Therapeutics.
Article Tags 
adams benckiser group reckitt respiratory takeover therapeutics
Both companies announced that they had received an early termination of the waiting period under the Hart Scott Rodino Antitrust Improvements Act.
Adams Respiratory Therapeutics manufactures cough and congestion medicine.
Reckitt Benckiser agreed to buy the company in December 2007 for £1.16 billion.
This article is copyrighted by the International Business Times.
Most Popular Stories
- 1 RBS gets Chinese approval for Suzhou stake
- 2 June retail sales fall less than expected
- 3 Auction-rate buybacks add to worries
- 4 Pound hits near 12-year low
- 5 Mortgage approvals hold near record low in July
- 6 Kazakhmys earnings down as bad weather hits
- 7 Miliband urges coalition against Russia in Georgia
- 1 Could $100 oil turn dumps into plastic mines?
- 2 Era of exclusive video game deals ending
- 3 Auction-rate buybacks add to worries
- 4 Audit shows China mismanaged 3.7 bln pounds
- 5 Gold firms near 2-week highs on oil, physicals support
- 6 Investors lift stocks, keep exposure thin
- 7 Councils seek powers to offer mortgages
|
Top Stories on Companies
- 1 RBS gets Chinese approval for Suzhou stake
- 2 Regus profit soars in first half
- 3 PartyGaming CEO targets DoJ resolution this year
- 4 Zoom Airlines grounds planes and files for bankruptcy
- 5 B&B sinks to first-half loss
- 6 Hunting's profit rises 11 pct on high oil prices
- 7 IMI posts profit and sees more progress
|
|
